MedPath
FDA Approval

Valganciclovir

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
September 8, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Valganciclovir(450 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Legacy Pharmaceutical Packaging, LLC

McKesson Corporation DBA SKY Packaging

143213275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valganciclovir

Product Details

NDC Product Code
63739-076
Application Number
ANDA205166
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 8, 2023
CROSPOVIDONEInactive
Code: 68401960MKClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 4P3T9QF9NZClass: ACTIRQuantity: 450 mg in 1 1
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
© Copyright 2025. All Rights Reserved by MedPath